Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Buske

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Cell Communication and Signaling : CCS|May 20, 2025
GPR15LG binds CXCR4 and synergistically modulates CXCL12-induced cell signaling and migrationDan Pascal Jean Albers, Sofya Novikova, Julio Vieyto-Nuñez, et al.
Experimental Hematology|July 13, 2015
MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemiaBernhard Gentner, Nicole Pochert, Arefeh Rouhi, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 23, 2021
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III StudyLarry W Kwak, Juan-Manuel Sancho, Seok-Goo Cho, et al.
Haematologica|June 29, 2019
Glutathione peroxidase 4 and vitamin E control reticulocyte maturation, stress erythropoiesis and iron homeostasisSandro Altamura, Naidu M Vegi, Philipp S Hoppe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemiaFriederike Pastore, Annika Dufour, Tobias Benthaus, et al.
The Lancet. Oncology|December 14, 2016
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trialMeletios A Dimopoulos, Judith Trotman, Alessandra Tedeschi, et al.
Blood|June 2, 2011
Comprehensive analysis of mammalian miRNA* species and their role in myeloid cellsFlorian Kuchenbauer, Sarah M Mah, Michael Heuser, et al.
Blood|May 5, 2023
A noncanonical enzymatic function of PIWIL4 maintains genomic integrity and leukemic growth in AMLShiva Bamezai, Alex Jose Pulikkottil, Tribhuwan Yadav, et al.
Leukemia|November 26, 2022
Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's MacroglobulinemiaIrene Dogliotti, Cristina Jiménez, Marzia Varettoni, et al.
Seminars in Hematology|April 26, 2023
Report of consensus panel 1 from the 11<sup>th</sup> International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-naïve patientsChristian Buske, Jorge J Castillo, Jithma Prasad Abeykoon, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Cell Communication and Signaling : CCS|May 20, 2025
GPR15LG binds CXCR4 and synergistically modulates CXCL12-induced cell signaling and migrationDan Pascal Jean Albers, Sofya Novikova, Julio Vieyto-Nuñez, et al.
Experimental Hematology|July 13, 2015
MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemiaBernhard Gentner, Nicole Pochert, Arefeh Rouhi, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 23, 2021
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III StudyLarry W Kwak, Juan-Manuel Sancho, Seok-Goo Cho, et al.
Haematologica|June 29, 2019
Glutathione peroxidase 4 and vitamin E control reticulocyte maturation, stress erythropoiesis and iron homeostasisSandro Altamura, Naidu M Vegi, Philipp S Hoppe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemiaFriederike Pastore, Annika Dufour, Tobias Benthaus, et al.
The Lancet. Oncology|December 14, 2016
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trialMeletios A Dimopoulos, Judith Trotman, Alessandra Tedeschi, et al.
Blood|June 2, 2011
Comprehensive analysis of mammalian miRNA* species and their role in myeloid cellsFlorian Kuchenbauer, Sarah M Mah, Michael Heuser, et al.
Blood|May 5, 2023
A noncanonical enzymatic function of PIWIL4 maintains genomic integrity and leukemic growth in AMLShiva Bamezai, Alex Jose Pulikkottil, Tribhuwan Yadav, et al.
Leukemia|November 26, 2022
Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's MacroglobulinemiaIrene Dogliotti, Cristina Jiménez, Marzia Varettoni, et al.
Seminars in Hematology|April 26, 2023
Report of consensus panel 1 from the 11<sup>th</sup> International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-naïve patientsChristian Buske, Jorge J Castillo, Jithma Prasad Abeykoon, et al.
Pageof 15